Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Evaluation of Beta Blocker and Angiotensin Converting Enzyme Inhibitor (ACEI) /Angiotensin Receptor Blocker (ARB) Treatment in MINOCA Patients.

NCT03686696 is registered in ClinicalTrials.gov with Uppsala University as lead sponsor.

NCT NCT03686696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03686696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Evaluation of Beta Blocker and Angiotensin Converting Enzyme Inhibitor (ACEI) /Angiotensin Receptor Blocker (ARB) Treatment in MINOCA Patients.
Lead sponsor
Uppsala University
Phase
Phase 4
Overall status
Terminated
Start date
December 16, 2018
Completion date
August 22, 2023
Enrollment
198 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction with non-obstructive coronary arteries